ABSTRACT
Purpose: The aim of the present study was to systematically evaluate the implant survival rate after osteotome-mediated maxillary sinus augmentation with or without using grafting materials.
Materials and Methods: MEDLINE database was searched using a combination of specific search terms. Furthermore, a hand searching of the relevant journals and of the bibliographies of reviews was performed. Prospective and retrospective clinical studies with at least 20 patients treated by osteotome-mediated sinus floor elevation were included.
Results: Nineteen studies were selected for data analysis. A total of 1,822 patients, accounting for 3,131 implants were considered. Mean weighted cumulative implant survival at 1, 2, 3, and 5 years was estimated as 98.12%, 97.40%, 96.75%, and 95.81%, respectively. No significant difference was found in relation to the use of grafting material nor in relation to implant length. Overall implant survival was 92.7% for 331 implants placed in <5 mm ridge height and 96.9% for 2,525 implants inserted in ≥5 mm ridge height. The difference was significant (p = .0003).
Conclusions: The transalveolar sinus augmentation technique could be a viable treatment in case of localized atrophy in the posterior maxilla even in case of minimal residual bone height. The prognosis can be more favorable when the residual ridge is at least 5 mm high.
Orthopedic and maxillofacial surgeons sometimes prepare for surgery by creating physical models of 3D scans of bones that they need to work on. Such models are also useful in educating med school students, doctors, and patients. However, these models tend to be very expensive, usually seen only in well-funded research projects or used by expensive medical professionals. Oftentimes, because the cost of the model is so high, a compromise must be made, so the resulting models end up being truncated or less than actual size.
Bone grafting is the use of either native, cadaveric, or artifical bone pieces to fill a void where you would like new bone to grow. Often at first, bone grafts have poor structural qualities and need hardware to protect them, the bone around and to keep them in place. In Oral-Maxillofacial surgery bone loss is often caused by infection, trauma, tumors and other conditions. 
Perhaps someday, the bi-annual trip to the dentist may become much less intimidating, thanks to researchers at Leeds University in the UK who have developed a completely pain-free way to fill cavities.
NovaBone Products has introduced a new line of biologically active bone-graft substitutes that are designed to enhance the body’s natural healing process by facilitating rapid vascularization and mineralization. Suspended in a rapidly-absorbable binder, the moldable material contains a calcium phosphosilicate with a continuous macroporous structure. Known as MacroPor-Si+, the product can be used to repair osseous defects throughout the skeletal system.
Posts
